Prevention of Immunological Disorders in MRL/I Mice by a New Synthetic Analogue of Vitamin D3: 22-Oxa-lα,25-Dihydroxyvitamin D3

journal of nutritional science and vitaminology

Volumn 36, Issue 1, 1990, Pages 21-31

  Abe, Junko ^a   Nakamura, Keiko ^a   Takita, Yumiko ^a   Nakano, Toshiaki ^a   Nishii, Yasuho ^a   Irie, Hiroshi ^b  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b Kanto Chuo Hospital   (Japan)

Author keywords

1 ,25(OH)2D3; 22 oxa 1 ,25(OH)2D3; autoimmune disorders; immunoregulating activity; MRL Mp lpr lpr mice

Indexed keywords

22 OXACALCITRIOL;

ANIMAL CELL; ARTICLE; IMMUNOREGULATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PROTEINURIA;

ANIMAL; ANTIGENS, SURFACE; ANTINEOPLASTIC AGENTS; AUTOIMMUNE DISEASES; CALCITRIOL; CHOLECALCIFEROL; KIDNEY; KNEE JOINT; MALE; MICE; MICE, INBRED STRAINS; ORGAN SPECIFICITY; PROTEINURIA; SPECIFIC PATHOGEN-FREE ORGANISMS;

ANIMALIA;

EID: 0025375701     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.36.21     Document Type: Article

References (17)

1. Abe, E., Miyaura, C., Sakagami, H., Takeda, M., Konno, K., Yamazaki, T., Yoshiki, S., and Suda, T. (1981): Differentiation of mouse myeloid leukemia cells induced by la, 25-dihydroxyvitamin D3. Proc. Natl. Acad. Sci. USA, 78, 4990-4994.
2. Abe, J., Moriya, Y., Saito, M., Sugawara, Y., Suda, T., and Nishii, Y. (1986): Modulation of cell growth, differentiation, and production of interleukin-3 by la, 25-dihydroxyvitamin D3 in the murine myelomonocytic leukemia cell line WEHI-3. Cancer Res., 46, 6316-6321.
3. Abe, J., Kondo, S., Nishii, Y., and Kuroki, T. (1989): Resistance to 1, 25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin. J. Clin. Endoclinol. Metab., 68, 851-854.
4. Reinhardt, T.A., Horst, R.L., Littledike, E.T., and Beitz, D.C. (1982): 1, 25-Dihydroxyvitamin D3 receptors in bovine thymus gland. Biochem. Biophys. Res. Commun., 106, 1012-1018.
5. Provvedini, D.M., Tsoukas, C.D., Deftos, L.J., and Manolagas, S.C. (1983): 1α, 25-Dihydroxyvitamin D3-receptor in human leukocytes. Science, 221, 1181-1183.
6. Kubodera, N., Miyamoto, K., Ochi, K., and Matsunaga, I. (1986): Synthetic studies of vitamin D analogues. VII. Synthesis of 20-oxa-21-norvitamin D3 analogues. Chem. Pharm. Bull., 34, 2286-2289.
7. Murayama, E., Miyamoto, K., Kubodera, N., Mori, T., and Matunaga, I. (1986): Synthetic studies of vitamin D analogues. VIII. Synthesis of 22-oxavitamin D3 analogues. Chem. Pharm. Bull, 34, 4410-4413.
8. Abe, J., Morikawa, M., Miyamoto, K., Kaiho, S., Fukushima, M., Miyaura, C., Abe, E., Suda, T., and Nishii, Y. (1987): Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton. FEES Lett., 226, 58-621.
9. Abe, J., Takita, Y., Nakano, T., Miyaura, C., Suda, T., and Nishii, Y. (1989): A synthetic analogue of vitamin D3, 22-oxa-la, 25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice. Endocrinology, 124, 2645-2647.
10. Murphy, E.D., and Rpths, J.B. (1977): A single gene model for massive lymphoprolife-ration with autoimmunity in new mouse strain MRL. Fed. Proc., 36, 1246.
11. Andrew, B.S., Eisenberg, R.A., Teolilopoulos, A.N., Izui, S., Wilson, C.B., McConahey, P.J., Murphy, E.D., Roths, J.B., and Dixon, F.J. (1978): Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestation in several strains. J. Exp. Med., 148, 1198-1215.
12. Hang, L., Theolilopoulos, A.N., and Dixon, F.J. (1982): A spontaneous rheumatoid arthritis-like disease in MRL/1 mice. J. Exp. Med., 155, 1690-1701.
13. Okudaira, H., Ogita, T., Miyamoto, T., Shiga, J., Suko, M., Okudaira, K., Terada, E., Ghoda, A., Terada, K., Saito, M., and Nomura, T. (1986): Interstitial pneumonitis in autoimmune MRL/lpr mice and its treatment with cyclosporin A. Clin. Immuno. Immunopathol., 38, 47-54.
14. O'Sullivan, F.X., Fassbevder, H.G., Gay, S., and Koopman, W.J. (1985): Etiopathogenesis of the rheumatoid arthritis-like disease in MRL/1 mice. I. The histmorphologic basis of joint destruction. Arthritis Rheum., 28, 529-536.
15. Steinberg, A.D., Roths, J.B., Murphy, E.D., Steinberg, R.T., and Raveche, E.S. (1980): Effects of thymectomy on androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J. Immunol., 125, 871-873.
16. Theofilopoulos, A.N., Balderas, R.S., Shawler, D.L., Lee, S., and Dixon, F.J. (1981): Influence of thymic genotype on the SLE-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice. J. Exp. Med., 153, 1405-1414.
17. Izui, S., McConahey, P.J., and Dixon, F.J. (1978): Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease. J. Immunol 121, 2213-2219.